Animal Stem Care

Animal Stem Care is a research, development and innovation company working in regenerative medicine focused on the treatment with Mesenchymal Stem Cells (MSC) of animals suffering from various diseases particularly, but not exclusively, orthopedic disorders.

Offers an extensive range of new therapies using adult stem cells to treat various tissues such as bones, tendons, ligaments and cartilage, among others. Animal Stem Care always uses Mesenchymal Stem Cells (MSC) without any genetic modification.  Is one of the few European companies that offers MSC derived from adipose tissue, bone marrow, umbilical cord and dental pulp for therapeutic use in horses, dogs and cats.

The production of stem cells from different origins guarantees a professional oriented service to veterinary hospitals and clinics.

Stem cell therapy primarily potentiates the regenerative capacity of the body itself. In addition, under certain circumstances these cells can divide, differentiate and promote the repair of damaged tissues.

Animal Stem Care only uses adult stem cells. These cells are obtained from variety of tissues including bone marrow, adipose tissue and Wharton's jelly of the umbilical cord. All these cells have similar properties, among others, the ability to release trophic factors capable of inducing tissue repair and also are able to differentiate relatively easily to chondrocytes, adipocytes and osteoblasts, which therefore can help regenerate cartilage, tendons, bone, etc.

Products in the catalog:

• AnimalStem SVF Direct: Stromal Vascular Fraction (SVF) of adipose tissue for 'SameDayTreatment'
• Direct plus SVF AnimalStem cat: Stromal Vascular Fraction (SVF) of adipose tissue in PRP for 'SameDayTreatment' in cat
• Direct AnimalStem SVF plus dog: Stromal Vascular Fraction (SVF) of adipose tissue in PRP for 'SameDayTreatment' in dog
• Pure AnimalStem AD: Adipose Tissue Stem Cells (ADSC) active after the cell culture> 95% viability
• Pure AnimalStem BM: Stem Cell Bone Marrow (BM-MSC) active after the cell culture> 95% viability
• Pure iv AnimalStem S: Intravenous Therapy ADSC active cell culture (Animal <15kg)
• Pure iv AnimalStem XL: Intravenous Therapy ADSC active cell culture (Animal> 15kg)
• AnimalStem allogenic AD: active ADSC cell culture after cell banking, neg. for virus
• AnimalStem allogenic BM: active BM-MSC cell culture after cell banking, neg. for virus
• EQ AnimalStem sys: same day therapy with SVF followed by active ADSC cell culture
• EQ AnimalStem iv: intravenous therapy with active ADSC cell culture
• AnimalStem banking: storage each year after the first year which is free
• AnimalStem frozen: Thaw, cultivation and treatment (ADSC, BM-MSC, umbilical cord, dental pulp)

• Optimization of the administration of stem cells from different origins with PRP and/or hydrogels.
• Safety and efficacy of the combined treatment of stem cells together with the usual antiparasitic treatments.

Research, development and distribution:

• Autologous and allogeneic therapies with stem cells.
• Endogenous regenerative factors.
• Products derived from plasma and blood.